SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PSDV - pSivida Limited
PSDV 1.220+14.0%Mar 29 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Arthur Radley who wrote (348)12/28/2010 9:44:16 AM
From: John McCarthy   of 421
 
Hi Arthur

That was great news ......

I heard the ALIM cc and have dumbed it down to .....

If you use Iluvien -

* you WILL get cataracks
* and the FDA is trying to see how often.

I am hanging (not selling) and while you might not agree with or follow my logic *hope* it falls to below $3.00 ...
even $2.00 ...

would then like the (risk versus reward thingie)
and put in for JUST a few more .....

I don't think the Mod. ARTS or ARTS come into play -
just Intent to Treat

BUT - if CATARACKS develop *continuoulsy* over the
course timeline of treatment - months 18 --> 36

we is gonna get booted down the block and become
a non-event historical footnote in biotech ...


So - dead money for 6 months and then we see ...

regards
John
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext